1. BCG and Novel Tuberculosis Vaccine Candidates in the Context of Immunodeficiencies
   Stefan H. E. Kaufmann, 2020, Encyclopedia of Medical Immunology CrossRef
2. A genomic analysis of Mycobacterium immunogenum strain CD11_6 and its potential role in the activation of T cells against Mycobacterium tuberculosis
   Gurpreet Kaur et al, 2019, BMC Microbiology CrossRef
3. Vaccine delivery systems against tuberculosis
   Rupal Ojha et al, 2020, Nanotechnology Based Approaches for Tuberculosis Treatment CrossRef
4. A Phase I/II randomized trial of H56:IC31 vaccination and adjunctive cyclooxygenase-2-inhibitor treatment in tuberculosis patients
   Synne Jenum et al, 2021, Nature Communications CrossRef
5. Meeting report: 5th Global Forum on TB Vaccines, 20–23 February 2018, New Delhi India
   Krishnamohan Atmakuri et al, 2018, Tuberculosis CrossRef
6. Tuberculosis Vaccines: An Update of Recent and Ongoing Clinical Trials
   Sean Saramago et al, 2021, Applied Sciences CrossRef
7. Controlled Human Infection Models To Accelerate Vaccine Development
   Robert K. M. Choy et al, 2022, Clinical Microbiology Reviews CrossRef
8. Tuberculosis vaccine developments and efficient delivery systems: A comprehensive appraisal
   Rasoul Hoseinpour et al, 2024, Heliyon CrossRef
9. Modulation of immune responses using adjuvants to facilitate therapeutic vaccination
   Virgil Schijns et al, 2020, Immunological Reviews CrossRef
10. Alzheimer’s Disease: Protective Effects of Mycobacterium vaccae, a Soil-Derived Mycobacterium with Anti-Inflammatory and Anti-Tubercular Properties, on the Proteomic Profiles of Plasma and Cerebrospinal Fluid in Rats
    Kelsey M. Loupy et al, 2020, Journal of Alzheimer's Disease CrossRef
11. The current status, challenges, and future developments of new tuberculosis vaccines
    Wenping Gong et al, 2018, Human Vaccines & Immunotherapeutics CrossRef
12. Clinical Development of New TB Vaccines: Recent Advances and Next Steps
    Mark Hatherill et al, 2020, Frontiers in Microbiology CrossRef
13. Mycobacterium tuberculosis: immune response, biomarkers, and therapeutic intervention
    Li Zhuang et al, 2024, MedComm CrossRef
14. Phase III, placebo-controlled, randomized, double-blind trial of tableted, therapeutic TB vaccine (V7) containing heat-killed M. vaccae administered daily for one month
    Aldar S. Bourinbaiar et al, 2020, Journal of Clinical Tuberculosis and Other Mycobacterial Diseases CrossRef
15. Proteogenomic Analysis and Discovery of Immune Antigens in Mycobacterium vaccae
    Jianhua Zheng et al, 2017, Molecular & Cellular Proteomics CrossRef
16. Effects of Mycobacterium vaccae vaccine in a mouse model of tuberculosis: protective action and differentially expressed genes
    Wen-Ping Gong et al, 2020, Military Medical Research CrossRef
17. Advancing Immunotherapeutic Vaccine Strategies Against Pulmonary Tuberculosis
    Sam Afkhami et al, 2020, Frontiers in Immunology CrossRef
18. BCG and Novel Tuberculosis Vaccine Candidates in the Context of Immunodeficiencies
    Stefan H. E. Kaufmann, 2020, Encyclopedia of Medical Immunology CrossRef
19. Novel approaches to tuberculosis vaccine development
    Stefan H.E. Kaufmann et al, 2017, International Journal of Infectious Diseases CrossRef
20. Prospects for a vaccine to prevent HIV-related tuberculosis
    Elisa Nemes et al, 2018, Current Opinion in HIV and AIDS CrossRef
21. Neue Impfstoffe gegen Tuberkulose
    Stefan H. E. Kaufmann, 2020, Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz CrossRef
22. Tuberculosis control by novel vaccines development and Indian initiatives
    Prasanta Kumar Ghosh, 2023, MGM Journal of Medical Sciences CrossRef
23. Vaccination Against Tuberculosis: Revamping BCG by Molecular Genetics Guided by Immunology
    Stefan H. E. Kaufmann, 2020, Frontiers in Immunology CrossRef